about
Association of endothelial nitric oxide synthase gene polymorphisms with coronary artery disease: an updated meta-analysis and systematic reviewInterleukin-1 Gene Cluster Polymorphisms and Their Association with Coronary Artery Disease: Separate Evidences from the Largest Case-Control Study amongst North Indians and an Updated Meta-AnalysisPatterns and determinants of dyslipidaemia in 'Young' versus 'Not so Young' patients of coronary artery disease: a multicentric, randomised observational study in northern India.Pharmacological measures to increase HDL-C among high risk isolated low HDL cases: a randomized study amongst north Indians.Differential Release Kinetics of Cardiac Biomarkers in Patients Undergoing Valve Replacement Surgery.Release kinetics of cardiac biomarkers in patients undergoing valve replacement surgery for rheumatic heart disease.Differential release kinetics of cardiac biomarkers in off-pump coronary bypass.Differential release kinetics of cardiac biomarkers in patients undergoing off pump coronary artery bypass surgery.Association of serum lipids and coronary artery disease with polymorphisms in the apolipoprotein AI-CIII-AIV gene cluster.Association of V249I and T280M polymorphisms in the chemokine receptor CX3CR1 gene with early onset of coronary artery disease among North Indians.Lack of association between Glu298Asp polymorphism and coronary artery disease in North Indians.Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary interventionQualitative and quantitative neointimal characterization by optical coherence tomography in patients presenting with in-stent restenosisDo outcomes following intervention for drug-eluting stent restenosis depend on whether the restenosed stent was polymer-free or polymer-coated?Optical coherence tomography tissue coverage and characterization with grey-scale signal intensity analysis after bifurcation stenting with a new generation bioabsorbable polymer drug-eluting stentVery late scaffold thrombosis after everolimus-eluting bioresorbable scaffold implantation in patients with unremarkable interim surveillance angiography
P50
Q26859156-13260290-054C-428E-BB2C-1C8A60A806BAQ35990069-4E8B69DD-D021-4485-BB79-58072223A714Q37387236-D01E6F86-E7F7-4320-AB6D-41E6F84D64BBQ37690828-2B1746C0-B81F-4157-8A44-4CE06BBDE24AQ39209393-9604988C-51B3-4C94-A72E-D319B8497A0DQ46915782-2C43B8F3-EC4D-4FB9-B56B-3E4B7B76472DQ48741887-E80596FC-DA23-4D2C-897E-0506D2060F8EQ50200327-93F75144-0CE0-4B27-824F-B91E5FFF3520Q51271590-AD819A63-A46A-4D22-AF1C-2EECBF30F24EQ53879294-52B7092E-CBF7-4F97-9A1D-F33FF0EDCB7AQ54331918-079FBFF8-BC45-4A07-8E5F-40CB4F24F787Q64116124-B340F9DA-4B26-4BEA-B50C-6FFFB781E3EBQ91731634-1CBECAE5-E0F5-45CC-9C56-31B507960827Q92410050-A89A21BF-41C0-434B-BCC7-FC0BF216997DQ92472240-7D91B6EE-4641-4C1D-9F4A-C41584BC7766Q92969231-C12DF959-E5CF-4EF2-AFAE-6D0688785FFC
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Himanshu Rai
@ast
Himanshu Rai
@en
Himanshu Rai
@es
Himanshu Rai
@nl
type
label
Himanshu Rai
@ast
Himanshu Rai
@en
Himanshu Rai
@es
Himanshu Rai
@nl
prefLabel
Himanshu Rai
@ast
Himanshu Rai
@en
Himanshu Rai
@es
Himanshu Rai
@nl
P106
P31
P496
0000-0003-3917-1934